UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 19, 2010
JOHN B. SANFILIPPO & SON, INC.
(Exact Name of Registrant as Specified in Charter)
| |
|
|
|
|
Delaware
(State or Other Jurisdiction of Incorporation)
|
|
0-19681
(Commission File Number)
|
|
36-2419677
(I.R.S. Employer Identification Number) |
1703 North Randall Road, Elgin, Illinois 60123-7820
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (847) 289-1800
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
John B. Sanfilippo & Son, Inc. (the “Registrant”) submits the following information:
ITEM 8.01. Other Events.
On March 19, 2010, the Registrant issued a press release regarding its voluntary recall of certain
bulk and packaged snack mix and cashew items containing black pepper as a precautionary measure
because the product may be contaminated with salmonella. The Registrant’s recall was a follow-up to
the voluntary recall of black pepper announced by Mincing Overseas Spice Company, a supplier to the
Registrant through a distributor, on March 5, 2010. The Registrant believes that the retail value
of the affected products that have been shipped to customers during the recall period and that are
currently in the market place is approximately $0.6 million. The potential financial impact of
other aspects and consequences of the recall, including the cost of retrieval, return and disposal
of the Registrant’s products impacted by the recall, is unknown.
This voluntary recall is in line with United States Food & Drug Administration recommendations, and
the Registrant has removed all of the Registrant’s products impacted by the recall within its
existing inventory, which inventory is valued at approximately $0.1 million.
The press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
ITEM 9.01. Financial Statements and Exhibits
(c) Exhibits
The exhibit furnished herewith is listed in the Exhibit Index which follows the signature page
of this Current Report on Form 8-K.